The RAGE–Ferroptosis Axis Drives Oxidative Stress-Associated Inflammatory Lung Injury in Viral Infection
Antioxidants · 31.03.2026 · 15 (4) · 434
DOI: 10.3390/antiox15040434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 31.03.2026. Verfasst von Wenhui Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, Chinese National Influenza Center, National Institute for…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Natural Scientific Foundation of China.
Abstract (Originalsprache)
The receptor for advanced glycation end-products (RAGE) is a lung-enriched pattern recognition receptor implicated in inflammatory responses. Its role in ferroptosis-mediated lung injury during viral infection, however, remains unclear. Here, we combined bioinformatics analysis with in vitro and in vivo experimental validation to investigate the RAGE–ferroptosis axis in influenza virus infection. Cross-analysis of RAGE- and ferroptosis-related genes identified overlapping candidates, suggesting functional crosstalk. Influenza-infected A549 cells exhibited ferroptotic cell death, characterized by Fe2+ accumulation, reactive oxygen species (ROS) elevation, and lipid peroxidation, which was markedly attenuated by the RAGE inhibitor FPS-ZM1. In A/PR/8/34 (H1N1)-infected female C57BL/6J mice, FPS-ZM1 treatment improved survival, reduced lung injury, restored redox balance, and modulated key ferroptosis regulators ACSL4, POR, and GPX4. Moreover, RAGE inhibition decreased M1 macrophage and neutrophil infiltration and reduced pro-inflammatory cytokines. Collectively, these findings reveal that RAGE activation drives ferroptosis and amplifies oxidative stress–associated lung injury, whereas RAGE inhibition mitigates tissue damage via the ACSL4/POR/GPX4 pathway and immunomodulation. This study identifies the RAGE–ferroptosis axis as a potential therapeutic target for severe pulmonary inflammation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Cont…
- Department of Health Inspection and Quarantine, School of Public Health, Public Health College, Anhui Medical University, Hefei 230032, China.
ORCID-Profile: Wenhui Guo, Haijun Zhu, Rongbao Gao
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Natural Scientific Foundation of China
Zitieren
APA
Guo, W., Luo, J., Pu, S., Cui, S., Zhu, H., He, P., & Gao, R. (2026). The RAGE–Ferroptosis Axis Drives Oxidative Stress-Associated Inflammatory Lung Injury in Viral Infection. Antioxidants, 15(4), 434. https://doi.org/10.3390/antiox15040434
Vancouver
Guo W, Luo J, Pu S, Cui S, Zhu H, He P, et al. The RAGE–Ferroptosis Axis Drives Oxidative Stress-Associated Inflammatory Lung Injury in Viral Infection. Antioxidants. 2026;15(4):434. doi:10.3390/antiox15040434
BibTeX
@article{Guo2026,
author = {Guo, Wenhui and Luo, Junhao and Pu, Siyu and Cui, Simin and Zhu, Haijun and He, Peiqing and Gao, Rongbao},
title = {The RAGE–Ferroptosis Axis Drives Oxidative Stress-Associated Inflammatory Lung Injury in Viral Infection},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {434},
doi = {10.3390/antiox15040434}
}
EUVIMED